Biodesix (BDSX) Payables (2019 - 2026)

Biodesix (BDSX) has reported Payables for 8 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• Payables for Q1 2026 came in at $3.7 million, up 24.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 24.13% YoY), and the FY2025 annual result was $3.1 million, up 39.32% from the prior year.
• Payables was $3.7 million for Q1 2026 at Biodesix, up from $3.1 million in the prior quarter.
• Over five years, Payables peaked at $16.4 million in Q3 2022 and troughed at $1.6 million in Q1 2023.
• Average Payables over 5 years is $4.2 million, with a median of $3.0 million recorded in 2023.
• Year-over-year, Payables soared 914.44% in 2022 and tumbled 82.03% in 2023.
• Over 5 years, Payables stood at $1.7 million in 2022, then surged by 71.86% to $3.0 million in 2023, then retreated by 25.67% to $2.2 million in 2024, then jumped by 39.32% to $3.1 million in 2025, then climbed by 18.37% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.7 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.